tetraethylammonium has been researched along with Hypertrophy, Left Ventricular in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogiwara, K | 1 |
| Ohya, S | 1 |
| Suzuki, Y | 1 |
| Yamamura, H | 1 |
| Imaizumi, Y | 1 |
1 other study available for tetraethylammonium and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Up-Regulation of the Voltage-Gated K
Topics: Animals; Blood Pressure; Delayed Rectifier Potassium Channels; Endothelium, Vascular; Hypertrophy, L | 2017 |